Effect of Hemodialysis on Total, Free And Percent-Free Prostate-Specific Antigen

mmustafa's picture
Journal Title, Volume, Page: 
African Journal of Urology, ISSN: 1110-5704, Vol. 12, No. 2, 2008, 75 - 78
Year of Publication: 
M. Mustafa
Department of Urology, Camlica Hayat Hospital, Istanbul, Turkey
Current Affiliation: 
Department of Medicine, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine
Bedier Ali-El-Dien
Urology and Nephrology Center, Mansoura University, Mansouram Egypt
Preferred Abstract (Original): 

Objective: To evaluate the effect of hemodialysis on serum total, free and percent free prostate specific antigen (PSA).
Patients and Methods: This study included 34 men with chronic renal failure (mean age 58 years, range 45-80) who received hemodialysis with low flux membranes. We measured pre- and post-hemodialy­ sis total PSA (tPSA), free PSA (fPSA) and hematocrit (Hte) at one dialysis session. Additionally, the percent fPSA to tPSA (fit PSA) ratio was calculated before and after dialysis. Htc was measured before and after dialysis to determine the degree of hemoconcentration and the correlation between PSA levels and Htc.
Results: There were statistically significant increments in the mean values of tPSA (pre-dialysis 1.2, post-dialysis 1.4 ng/ml) and f/tPSA ratio (pre-dialysis 28.2%, post­ dialysis 35.2%). In addition, a significant increase in Htc was noted after dialysis. The mean pre-dialysis fPSA was 0.4 and the post-dialysis value was 0.43 ng/ml (difference not statistically significant). The degree of hemoconcentration was not statistically correlated with the elevation in the values of tPSA, fPSA and f/tPSA.
Conclusions: Although the increment in tPSA was statistically significant, it was not clinically meaningful. The most likely explanation for the increment in tPSA and fPSA after hemodialysis is volume con­ traction, and hemodialysis with low flux membranes appears to have no effect on PSA clearance. Pre-dialysis determination of tPSA probably provides no false­ positive results. Therefore, we advocate that serum PSA determination is done in conjunction with digital rectal examination (ORE) and/or transrectal ultrasonography (TRUS) in patients on dialysis, especially those who are candidates for renal Trans plantation, to rule out prostate cancer.

Effect_of_Hemodialysis_on_Total_Free_And_Percent-Free_Prostate-Specific_Antigen.pdf.pdf366.71 KB